CP and neoplasm: The median concentrations of CP-AP in the collectives of healthy controls (HC), inflammatory controls (IC) and tumor patients (TP) were 10.3 (SD 3.1), 11.1 (SD 6.1) and 17.6 (SD 9.0) respectively (Figure 5A).